We are live on ! Find out more
MGCD

MGC Diagnostics Corporation
MGCD

Delisted

MGCD was delisted on the 28th of December, 2017.

Back to rankings

19 hedge funds and large institutions have $9.21M invested in MGC Diagnostics Corporation in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

11% more capital invested

Capital invested by funds: $8.27M → $9.21M (+$941K)

0% more funds holding

Funds holding: 19 → 19 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
19
Holders Change
–
Holders Change %
0%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$96.6K
2
Northern Trust
Northern Trust
Illinois
+$82.7K
3
Renaissance Technologies
Renaissance Technologies
New York
+$64.1K
4
Deutsche Bank
Deutsche Bank
Germany
+$9.71K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.95K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$6K
2
FM
Fondren Management
Texas
-$812
3
TRCT
Tower Research Capital (TRC)
New York
-$812
4
Bank of America
Bank of America
North Carolina
-$698
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$2.59M +$64.1K +7,895 +3%
PA
2
Perceptive Advisors
New York
$2.26M – – –
BlackRock
3
BlackRock
New York
$901K – – –
FM
4
Fondren Management
Texas
$871K -$812 -100 -0.1%
Vanguard Group
5
Vanguard Group
Pennsylvania
$724K +$2.95K +363 +0.5%
PCM
6
Perritt Capital Management
Illinois
$628K – – –
BGIM
7
Brandywine Global Investment Management
Pennsylvania
$397K – – –
Creative Planning
8
Creative Planning
Kansas
$323K – – –
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$197K +$96.6K +11,897 +118%
California Public Employees Retirement System
10
California Public Employees Retirement System
California
$146K – – –
Northern Trust
11
Northern Trust
Illinois
$91K +$82.7K +10,185 New
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$24K – – –
Deutsche Bank
13
Deutsche Bank
Germany
$21K +$9.71K +1,195 +104%
ASN
14
Advisory Services Network
Georgia
$15K – – –
PCM
15
Prelude Capital Management
New York
$15K – – –
JIR
16
James Investment Research
Ohio
$10K – – –
UBS Group
17
UBS Group
Switzerland
– -$6K -775 Closed
TRCT
18
Tower Research Capital (TRC)
New York
– -$812 -100 Closed
Bank of America
19
Bank of America
North Carolina
– -$698 -86 -86%
LTFS
20
Ladenburg Thalmann Financial Services
Florida
– +$211 +26 New

MGCD Hedge Fund Activity: Q3 2017 in Review

19 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in MGC Diagnostics Corporation (MGCD) for Q3 2017, worth a combined $9.21M — up 11% from $8.27M a quarter earlier.

Fund positioning in MGCD was balanced in Q3 2017: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 2 trimmed.

The largest buyer was Royal Bank of Canada, adding an estimated $96.6K. The largest seller was UBS Group, exiting entirely with an estimated $6K sold.

  • 19 institutional investors held MGC Diagnostics Corporation (MGCD) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $9.21M of MGC Diagnostics Corporation stock for Q3 2017, up 11% quarter-over-quarter.
  • 2 funds opened new MGC Diagnostics Corporation positions in Q3 2017 and 2 closed out, a net change of 0 holders.
  • The largest MGC Diagnostics Corporation buyer in Q3 2017 was Royal Bank of Canada, an estimated $96.6K added.
  • The largest MGC Diagnostics Corporation seller in Q3 2017 was UBS Group, an estimated $6K sold.

Based on aggregated 13F filings for Q3 2017.